Press Release: Roche’s collaborator MediLink announces phase III data for Tam-Peli showing significantly improved overall survival in Chinese patient population with relapsed small-cell lung cancer

Choose a language:

Globe NewsWire News Distribution Service

Details: Written by Globe NewsWire Press Releases; Category: Globe NewsWire News Distribution Service; Published: 13 September 2026; Created: 13 September 2026; Last Updated: 13 September 2026

Basel, 13 September 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) today announced that its collaborator MediLink released interim results from the randomised phase III TAISHAN-302 trial evaluating Tam-Peli (tambotatug pelitecan, YL201) versus topotecan in Chinese patients with relapsed small-cell lung cancer (SCLC) who progressed after prior platinum-based chemotherapy with or without a PD-L1 inhibitor.1…

Posted: 2026-09-13 00:00:00

Get Full News Story On GlobeNewsWire Press Release Service

More News From This Category
Press Release: Build-A-Bear Investor News: If You Have Suffered Losses in Build-A-Bear Workshop, Inc., You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Sun, 13 Sep 2026 04:08:03 +0000

NEW YORK, Sept. 12, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Build-A-Bear Workshop, Inc. (NYSE: BBW) resulting from allegations that Build-A-Bear may have issued materially misleading business information to the investing public.

Press Release: PARK HA DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PHH, BYAH
Sat, 12 Sep 2026 22:08:12 +0000

NEW YORK, Sept. 12, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) between December 27, 2024 and July 8, 2025, inclusive (the “Class Period”), of the important September 28, 2026 lead plaintiff deadline.

Press Release: CCOI 9-DAY DEADLINE ALERT: Cogent Communications Holdings, Inc. Investors Alerted to September 21, 2026 Lead Plaintiff Deadline in Securities Fraud Class Action
Sat, 12 Sep 2026 19:08:00 +0000

Investors who lost money in CCOI after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.

Press Release: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBNX
Sat, 12 Sep 2026 16:08:00 +0000

NEW YORK, Sept. 12, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the “Class Period”). A class action lawsuit has…

Related Bing News Results